247 related articles for article (PubMed ID: 32532513)
21. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
22. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
[TBL] [Abstract][Full Text] [Related]
23. Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions.
Zhu A; Gereta S; Zhang TR; Stangl-Kremser J; Mora RM; Margolis DJA; Hu JC
Eur Urol Open Sci; 2023 Jul; 53():38-45. PubMed ID: 37441341
[TBL] [Abstract][Full Text] [Related]
24. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study.
Ahmed HU; Dickinson L; Charman S; Weir S; McCartan N; Hindley RG; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Eur Urol; 2015 Dec; 68(6):927-36. PubMed ID: 25682339
[TBL] [Abstract][Full Text] [Related]
25. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
[TBL] [Abstract][Full Text] [Related]
26. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
[TBL] [Abstract][Full Text] [Related]
27. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
[TBL] [Abstract][Full Text] [Related]
28. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
[TBL] [Abstract][Full Text] [Related]
29. Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1-2b Study).
Sood A; Jeong W; Palma-Zamora I; Abdollah F; Butaney M; Corsi N; Wurst H; Arora S; Kachroo N; Hassan O; Gupta N; Gorin MA; Menon M
Eur Urol; 2022 Apr; 81(4):396-406. PubMed ID: 34872786
[TBL] [Abstract][Full Text] [Related]
30. Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone.
Wysock JS; Becher E; Gogaj R; Velazquez N; Lepor H
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):114-119. PubMed ID: 32636487
[TBL] [Abstract][Full Text] [Related]
31. Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
Garcia-Barreras S; Sanchez-Salas R; Sivaraman A; Barret E; Secin F; Nunes-Silva I; Linares-Espinós E; Rozet F; Galiano M; Cathelineau X
J Urol; 2018 Jan; 199(1):140-146. PubMed ID: 28823768
[TBL] [Abstract][Full Text] [Related]
32. Need for Systematic Magnetic Resonance Imaging Interpretation and Reporting after Partial Prostate Gland Ablation.
Hu JC; Basourakos SP; Futterer J
Eur Urol; 2021 Feb; 79(2):167-169. PubMed ID: 33221091
[TBL] [Abstract][Full Text] [Related]
33. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
34. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
35. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
36. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
Muller BG; Fütterer JJ; Gupta RT; Katz A; Kirkham A; Kurhanewicz J; Moul JW; Pinto PA; Rastinehad AR; Robertson C; de la Rosette J; Sanchez-Salas R; Jones JS; Ukimura O; Verma S; Wijkstra H; Marberger M
BJU Int; 2014 Feb; 113(2):218-27. PubMed ID: 24215670
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy.
Fasulo V; Cowan JE; Maggi M; Washington SL; Nguyen HG; Shinohara K; Lazzeri M; Casale P; Carroll PR
Eur Urol Oncol; 2022 Feb; 5(1):61-69. PubMed ID: 33069628
[TBL] [Abstract][Full Text] [Related]
38. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.
Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J
Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395
[TBL] [Abstract][Full Text] [Related]
39. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
Gross MD; Sedrakyan A; Bianco FJ; Carroll PR; Daskivich TJ; Eggener SE; Ehdaie B; Fisher B; Gorin MA; Hunt B; Jiang H; Klein EA; Marinac-Dabic D; Montgomery JS; Polascik TJ; Priester AM; Rastinehad AR; Viviano CJ; Wysock JS; Hu JC
J Urol; 2019 Nov; 202(5):952-958. PubMed ID: 31144591
[TBL] [Abstract][Full Text] [Related]
40. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
